Promotion of Hras-induced squamous carcinomas by a polymorphic variant of the Patched gene in FVB mice

Nature

Volumn 445, Issue 7129, 2007, Pages 761-765

  Wakabayashi, Yuichi ^a   Mao, Jian Hua ^a   Brown, Ken ^b,e   Girardi, Michael ^c   Balmain, Allan ^a,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e CXR Biosciences Ltd   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALLELE; APOPTOSIS; CANCER; CARCINOGEN; GENE EXPRESSION; PHENOTYPE; POLYMORPHISM; TUMOR;

ALLELE; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BASAL CELL CARCINOMA; CANCER RESISTANCE; CANCER STAGING; CANCER SUSCEPTIBILITY; CARBOXY TERMINAL SEQUENCE; CELL LINEAGE; CONTROLLED STUDY; DNA POLYMORPHISM; EARLY CANCER; GENE LOSS; GENE OVEREXPRESSION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HYBRID; MEDULLOBLASTOMA; MOUSE; MOUSE STRAIN; NONHUMAN; ONCOGENE RAS; PRIORITY JOURNAL; PROMOTER REGION; SKIN CARCINOGENESIS; SQUAMOUS CELL CARCINOMA; STRUCTURAL HOMOLOGY; TARGET CELL; TRANSGENIC MOUSE; TUMOR SUPPRESSOR GENE;

ERINACEIDAE; MUS;

EID: 33847138972     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/nature05489     Document Type: Article

References (29)

1. Hennings, H. et al. FVB/N mice: an inbred strain sensitive to the chemical induction of squamous cell carcinomas in the skin. Carcinogenesis 14, 2353-2358 (1993).
2. Hahn, H. et al. Mutations of the human homolog of Drosophila patched in the nevoid basal cell carcinoma syndrome. Cell 85, 841-851 (1996).
3. Johnson, R. L. et al. Human homolog of patched, a candidate gene for the basal cell nevus syndrome. Science 272, 1668-1671 (1996).
4. Gailani, M. R. et al. The role of the human homologue of Drosophila patched in sporadic basal cell carcinomas. Nature Genet. 14, 78-81 (1996).
5. Dahmane, N., Lee, J., Robins, P., Heller, P. & Ruiz i Altaba, A. Activation of the transcription factor Gli1 and the Sonic hedgehog signalling pathway in skin tumours. Nature 389, 876-881 (1997).
6. Brown, K., Strathdee, D., Bryson, S., Lambie, W. & Balmain, A. The malignant capacity of skin tumours induced by expression of a mutant H-ras transgene depends on the cell type targeted. Curr. Biol. 8, 516-524 (1998).
7. -/- stem/progenitor cells predisposes cells to undergo apoptosis, and surviving stem/progenitor cells display cytogenetic abnormalities and an increased risk of malignancy. Blood 105, 3465-3471 (2005).
8. Aszterbaum, M. et al. Ultraviolet and ionizing radiation enhance the growth of BCCs and trichoblastomas in patched heterozygous knockout mice. Nature Med. 5, 1285-1291 (1999).
9. Unden, A. B. et al. Mutations in the human homologue of Drosophila patched (PTCH) in basal cell carcinomas and the Gorlin syndrome: different in vivo mechanisms of PTCH inactivation. Cancer Res. 56, 4562-4565 (1996).
10. Arbeit, J. M., Munger, K., Howley, P. M. & Hanahan, D. Progressive squamous epithelial neoplasia in K14-human papillomavirus type 16 transgenic mice. J. Virol. 68, 4358-4368 (1994).
11. Chin, L. et al. Essential role for oncogenic Ras in tumour maintenance. Nature 400, 468-472 (1999).
12. Weinstein, I. B. Cancer. Addiction to oncogenes - the Achilles heal of cancer. Science 297, 63-64 (2002).
13. Thibert, C. et al. Inhibition of neuroepithelial patched-induced apoptosis by sonic hedgehog. Science 301, 843-846 (2003).
14. Barnes, E. A., Kong, M., Ollendorff, V. & Donoghue, D. J. Patched1 interacts with cyclin B1 to regulate cell cycle progression. EMBO J. 20, 2214-2223 (2001).
15. Goodrich, L. V., Milenković, L., Higgins, K. M. & Scott, M. P. Altered neural cell fates and medulloblastoma in mouse patched mutants. Science 277, 1109-1113 (1997).
16. Guerrero, I. & Ruiz i Altaba, A. Development. Longing for ligand: hedgehog, patched, and cell death. Science 301, 774-776 (2003).
17. Hooper, J. E. & Scott, M. P. Communicating with Hedgehogs. Nature Rev. Mol. Cell Biol. 6, 306-317 (2005).
18. Syken, J., De-Medina, T. & Münger, K. TID1, a human homolog of the Drosophila tumor suppressor l(2)tid, encodes two mitochondrial modulators of apoptosis with opposing functions. Proc. Natl Acad. Sci. USA 96, 8499-8504 (1996).
19. Canamasas, I., Debes, A., Natali, P. G. & Kurzik-Dumke, U. Understanding human cancer using Drosophila: Tid47, a cytosolic product of the DnaJ-like tumor suppressor gene l(2)Tid, is a novel molecular partner of Patched related to skin cancer. J. Biol. Chem. 278, 30952-30960 (2003).
20. Trentin, G. A. et al. A mouse homologue of the Drosophila tumor suppressor l(2)tid gene defines a novel Ras GTPase-activating protein (RasGAP)-binding protein. J. Biol. Chem. 276, 13087-13095 (2001).
21. Sarkar, S. et al. hTid-1, a human DnaJ protein, modulates the interferon signaling pathway. J. Biol. Chem. 276, 49034-49042 (2001).
22. Tarunina, M. et al. Functional genetic screen for genes involved in senescence: role of Tid1, a homologue of the Drosophila tumor suppressor l(2)tid, in senescence and cell survival. Mol. Cell. Biol. 24, 10792-10801 (2004).
23. Cheng, H. et al. Molecular mechanism of hTid-1, the human homolog of Drosophila tumor suppressor l(2)Tid, in the regulation of NF-κB activity and suppression of tumor growth. Mol. Cell. Biol. 25, 44-59 (2005).
24. Mao, J. H. & Balmain, A. Genomic approaches to identification of tumour susceptibility genes using mouse models. Curr. Opin. Genet. Dev. 13, 14-19 (2003).
25. Nagase, H. et al. Distinct genetic loci control development of benign and malignant skin tumours in mice. Nature Genet. 10, 424-429 (1995).
26. Perez-Losada, J. & Balmain, A. Stem-cell hierarchy in skin cancer. Nature Rev. Cancer 3, 434-443 (2003).
27. Quintanilla, M., Brown, K., Ramsden, M. & Balmain, A. Carcinogen-specific mutation and amplification of Ha-ras during mouse skin carcinogenesis. Nature 322, 78-80 (1986).
28. Janes, K. A. et al. A systems model of signaling identifies a molecular basis set for cytokine-induced apoptosis. Science 310, 1646-1653 (2005).
29. Taipale, J. et al. Effects of oncogenic mutations in Smoothened and Patched can be reversed by cyclopamine. Nature 406, 1005-1009 (2000).